SUPPLEMENT

Q4 2025 — Income statement trends

Q4 2025PDF · 2 pages212 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Q425
Revenues:
Clearing and transaction fees 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 1,388.0 1,227.9 1,327.9
Market data and information services 167.2 175.4 175.0 178.2 181.6 194.5 198.1 202.5 208.0
Other Revenue 87.6 103.6 107.6 109.1 111.4 110.5 105.9 107.2 112.8
Total revenues 1,439.3 1,487.9 1,532.5 1,584.4 1,525.3 1,642.3 1,692.0 1,537.6 1,648.7
Expenses:
Compensation and benefits 212.9 206.0 204.7 218.8 220.8 206.7 221.6 237.6 241.1
Technology 58.5 59.4 64.1 66.6 65.7 65.7 70.9 71.4 75.2
Professional fees and outside services 36.1 33.1 34.7 31.0 33.9 28.5 37.4 36.7 47.9
Amortization of purchased intangibles 55.6 55.2 55.5 55.7 55.3 55.2 56.1 56.2 55.9
Depreciation and amortization 30.7 30.1 28.7 28.2 28.1 27.3 27.3 26.4 26.5
Licensing and other fee agreements 80.4 87.9 85.9 97.6 84.0 96.6 96.2 81.6 96.6
Other expense 101.9 56.6 58.3 62.3 90.4 54.3 53.2 55.1 85.9
Operating expenses 576.1 528.3 531.9 560.2 578.2 534.3 562.7 565.0 629.1
Operating Income 863.2 959.6 1,000.6 1,024.2 947.1 1,108.0 1,129.3 972.6 1,019.6
Operating Margin 60% 64% 65% 65% 62% 67% 67% 63% 62%
Non-operating Income and Expense
Investment income 1,076.9 1,071.3 1,044.5 1,026.8 936.5 892.7 1,518.4 1,548.7 1,776.7
Interest and other borrowing costs (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) (44.0) (44.0) (43.7)
Equity in net gains (losses) of unconsolidated subsidiaries 66.8 87.2 86.4 86.1 91.2 88.2 99.0 96.3 88.2
Other non-operating income (expense) (961.2) (964.8) (936.9) (920.0) (837.5) (802.4) (1,372.4) (1,396.6) (1,262.4)
Non-operating income (expense) 142.8 153.8 153.9 152.7 149.5 136.8 201.0 204.4 558.8
Income before income taxes 1,006.0 1,113.4 1,154.5 1,176.9 1,096.6 1,244.8 1,330.3 1,177.0 1,578.4
Income taxes 191.4 258.2 271.3 264.1 222.0 288.6 305.2 269.0 395.5
Net income 814.6 855.2 883.2 912.8 874.6 956.2 1,025.1 908.0 1,182.9
Less: net income (loss) attributable to NCI - - - - - - - - -
Net Income Attributable to CME Group 814.6 855.2 883.2 912.8 874.6 956.2 1,025.1 908.0 1,182.9
Net Income Attributable to Common Shareholders of CME Group 804.3 844.4 872.1 901.3 863.7 944.2 1,012.2 896.6 1,168.0
Effective Tax Rate 19.0% 23.2% 23.5% 22.4% 20.2% 23.2% 22.9% 22.9% 25.1%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 2.24 2.35 2.43 2.51 2.40 2.63 2.81 2.49 3.25
Diluted EPS 2.24 2.35 2.42 2.50 2.40 2.62 2.81 2.49 3.24
Weighted average number of common stock shares:
Basic Shares 359,197 359,258 359,330 359,400 359,568 359,613 359,658 359,686 359,633
Diluted Shares 359,693 359,833 359,869 359,989 360,050 360,227 360,355 360,422 360,233
Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Q425
Revenues:
Clearing and transaction fees 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 1,388.0 1,227.9 1,327.9
Market data and information services 167.2 175.4 175.0 178.2 181.6 194.5 198.1 202.5 208.0
Other Revenue 87.6 103.6 106.6 109.2 111.3 110.5 105.9 107.2 112.8
Total revenues 1,439.3 1,487.9 1,531.5 1,584.5 1,525.2 1,642.3 1,692.0 1,537.6 1,648.7
Expenses:
Compensation and benefits 204.4 196.1 201.7 207.5 218.9 207.8 212.5 225.0 232.6
Technology 58.5 59.4 64.1 66.6 65.7 65.7 70.9 71.3 75.3
Professional fees and outside services 36.1 33.1 34.7 31.0 33.9 25.2 27.0 27.0 28.3
Amortization of purchased intangibles - - - - - - - - -
Depreciation and amortization 29.8 29.3 28.7 28.2 28.0 27.3 26.9 26.4 26.4
Licensing and other fee agreements 80.4 87.9 85.9 97.6 84.0 96.6 96.2 81.6 96.6
Other expense 80.3 56.5 58.6 57.9 89.7 52.0 57.7 55.3 84.2
Operating expenses 489.5 462.3 473.7 488.8 520.2 474.6 491.2 486.6 543.4
Operating Income 949.8 1,025.6 1,057.8 1,095.7 1,005.0 1,167.7 1,200.8 1,051.0 1,105.3
Operating Margin 66% 69% 69% 69% 66% 71% 71% 68% 67%
Non-operating Income and Expense
Investment income 1,068.5 1,061.7 1,033.0 1,022.3 943.8 892.3 1,510.7 1,542.1 1,424.4
Interest and other borrowing costs (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) (44.0) (44.0) (43.7)
Equity in net gains (losses) of unconsolidated subsidiaries 85.1 100.7 98.8 99.7 104.8 110.4 112.2 112.2 101.0
Other non-operating income (expense) (958.8) (964.8) (936.9) (920.0) (837.5) (802.4) (1,372.4) (1,396.6) (1,262.8)
Non-operating income (expense) 155.1 157.7 154.8 161.8 170.4 158.6 206.5 213.7 218.9
Income before income taxes 1,104.9 1,183.3 1,212.6 1,257.5 1,175.4 1,326.3 1,407.3 1,264.7 1,324.2
Income taxes 240.2 272.2 280.4 280.5 256.5 306.4 327.9 286.3 313.8
Net income 864.7 911.1 932.2 977.0 918.9 1,019.9 1,079.4 978.4 1,010.4
Less: net income (loss) attributable to NCI - - - - - - - - -
Net Income Attributable to CME Group 864.7 911.1 932.2 977.0 918.9 1,019.9 1,079.4 978.4 1,010.4
Net Income Attributable to Common Shareholders of CME Group 853.8 899.7 920.4 964.7 907.4 1,007.1 1,065.8 966.1 997.7
Effective Tax Rate 21.7% 23.0% 23.1% 22.3% 21.8% 23.1% 23.3% 22.6% 23.7%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 2.38 2.50 2.56 2.68 2.52 2.80 2.96 2.69 2.77
Diluted EPS 2.37 2.50 2.56 2.68 2.52 2.80 2.96 2.68 2.77
Weighted average number of common stock shares:
Basic Shares 359,197 359,258 359,330 359,400 359,568 359,613 359,658 359,686 359,633
Diluted Shares 359,693 359,833 359,869 359,989 360,050 360,227 360,355 360,422 360,233
Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584

-- 2 of 2 --